Clinical Trial Update: A Study of Nasal Glucagon in Participants With a Common Cold [Phase 1]

View source ↗

Summary

Phase 1 trial update for nasal glucagon in participants with a common cold; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Nasal Glucagon (glucagon)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Common Cold | Phase 1 | Status: COMPLETED | Results posted: 2019-09-18